Trial · NCT00326898
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Arm A (Sunitinib + Sorafenib Placebo) | 647 | |
| Overall Study | STARTED | Arm B (Sorafenib + Sunitinib Placebo) | 649 | |
| Overall Study | STARTED | Arm C (Sunitinib Placebo + Sorafenib Placebo) | 647 | |
| Overall Study | Patients With Toxicity Data | Arm A (Sunitinib + Sorafenib Placebo) | 625 | |
| Overall Study | Patients With Toxicity Data | Arm B (Sorafenib + Sunitinib Placebo) | 628 | |
| Overall Study | Patients With Toxicity Data | Arm C (Sunitinib Placebo + Sorafenib Placebo) | 626 | |
| Overall Study | Patients With Clear Cell Histology | Arm A (Sunitinib + Sorafenib Placebo) | 542 | |
| Overall Study | Patients With Clear Cell Histology | Arm B (Sorafenib + Sunitinib Placebo) | 540 | |
| Overall Study | Patients With Clear Cell Histology | Arm C (Sunitinib Placebo + Sorafenib Placebo) | 540 | |
| Overall Study | Patients With >=1 Follow-up MUGA Scan | Arm A (Sunitinib + Sorafenib Placebo) | 513 | |
| Overall Study | Patients With >=1 Follow-up MUGA Scan | Arm B (Sorafenib + Sunitinib Placebo) | 510 | |
| Overall Study | Patients With >=1 Follow-up MUGA Scan | Arm C (Sunitinib Placebo + Sorafenib Placebo) | 580 | |
| Overall Study | COMPLETED | Arm A (Sunitinib + Sorafenib Placebo) | 296 | |
| Overall Study | COMPLETED | Arm B (Sorafenib + Sunitinib Placebo) | 306 | |
| Overall Study | COMPLETED | Arm C (Sunitinib Placebo + Sorafenib Placebo) | 444 | |
| Overall Study | NOT COMPLETED | Arm A (Sunitinib + Sorafenib Placebo) | 351 | |
| Overall Study | NOT COMPLETED | Arm B (Sorafenib + Sunitinib Placebo) | 343 | |
| Overall Study | NOT COMPLETED | Arm C (Sunitinib Placebo + Sorafenib Placebo) | 203 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00326898/flow